Respiro Diagnostics

Leeds, United Kingdom

pre-seed$1.3M raisedDigital HealthBiotechDiagnostics

◆ Total Raised

$1.3M

◆ Stage

pre-seed

◆ Location

Leeds, United Kingdom

◆ Founded

2025

◆ Team size

1-10

◆ Links

Website ↗LinkedIn ↗

◆ About Respiro Diagnostics

UK-based startup developing breath-based diagnostics for lung diseases using non-invasive liquid biopsy technology.

◆ What sets it apart

Their platform captures clinically relevant molecular signals from the lungs using a simple breath-based sample, eliminating the need for invasive procedures, imaging, or radiation.

◆ Sectors

Digital HealthBiotechDiagnostics

◆ Business

Modelhardware

Customerhealthcare providers and patients undergoing lung cancer screening

◆ Notable

Received investment from Zinc!
Incorporated as RESPIRO DIAGNOSTICS LIMITED on 13 May 2025
Currently advancing toward clinical studies and commercial planning

◆ Funding rounds

pre-seed$1.3M

8 Jul 2026

Led by Zinc Venture Capital, SFC Capital

With Amadeus Capital Partners, Conception X Angel Syndicate, KQ Labs, Francis Crick Institute, Innovate UK

Source ↗

◆ Explore the market

Digital Health Biotech Diagnostics Pre-Seed United Kingdom

◆ FAQ

What does Respiro Diagnostics do?

UK-based startup developing breath-based diagnostics for lung diseases using non-invasive liquid biopsy technology.

Where is Respiro Diagnostics based?

Respiro Diagnostics is based in Leeds, United Kingdom, founded in 2025.

How much has Respiro Diagnostics raised?

Respiro Diagnostics has raised $1.3M in tracked funding and is currently at the pre-seed stage.

Who has invested in Respiro Diagnostics?

Investors in Respiro Diagnostics include Zinc!.